ArticleClinical pharmacology and therapeutics2021

Discovery of Nonracemic Amisulpride to Maximize Benefit/Risk of 5-HT7 and D2 Receptor Antagonism for the Treatment of Mood Disorders.

Seth C Hopkins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.